Clinical Trial Update: MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluation of lopinavir/ritonavir with interferon beta-1b for MERS-CoV has completed phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Middle East Respiratory Syndrome Coronavirus

Drugs mentioned

• Interferon beta-1b (Interferon beta-1b)
• Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: King Abdullah International Medical Research Center | Conditions: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) | Phase 2, Phase 3 | Status: COMPLETED